Chronic lymphocytic leukemia associated with immunotactoid glomerulopathy: a case report of successful treatment with high-dose methylprednisolone in combination with rituximab followed by alemtuzumab.
作者信息
Castro Januario E, Diaz-Perez Julio A, Barajas-Gamboa Juan S, Horton John M, Weidner Noel, Kipps Thomas J
出版信息
Leuk Lymphoma. 2012 Sep;53(9):1835-8. doi: 10.3109/10428194.2012.663914. Epub 2012 Mar 13.
Abstract
摘要
相似文献
1
Chronic lymphocytic leukemia associated with immunotactoid glomerulopathy: a case report of successful treatment with high-dose methylprednisolone in combination with rituximab followed by alemtuzumab.慢性淋巴细胞白血病合并免疫触须样肾小球病：高剂量甲泼尼龙联合利妥昔单抗治疗成功后序贯阿仑单抗的病例报告
Leuk Lymphoma. 2012 Sep;53(9):1835-8. doi: 10.3109/10428194.2012.663914. Epub 2012 Mar 13.
2
A phase I study of escalated dose subcutaneous alemtuzumab given weekly with rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma.一项Ⅰ期研究显示，每周皮下给予递增剂量的阿仑单抗联合利妥昔单抗治疗复发的慢性淋巴细胞白血病/小淋巴细胞淋巴瘤。
Haematologica. 2013 Jun;98(6):964-70. doi: 10.3324/haematol.2013.086207. Epub 2013 May 3.
3
Alemtuzumab in combination with methylprednisolone is a highly effective induction regimen for patients with chronic lymphocytic leukemia and deletion of TP53: final results of the national cancer research institute CLL206 trial.阿仑单抗联合甲泼尼龙是治疗慢性淋巴细胞白血病伴 TP53 缺失患者的一种高效诱导方案：国家癌症研究所 CLL206 试验的最终结果。
J Clin Oncol. 2012 May 10;30(14):1647-55. doi: 10.1200/JCO.2011.35.9695. Epub 2012 Apr 9.
4
Addition of granulocyte macrophage colony stimulating factor does not improve response to early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximab.添加粒细胞巨噬细胞集落刺激因子不能改善阿仑单抗和利妥昔单抗早期治疗高危慢性淋巴细胞白血病的反应。
Leuk Lymphoma. 2013 Mar;54(3):476-82. doi: 10.3109/10428194.2012.717276. Epub 2012 Aug 22.
5
[Chronic lymphocytic leukemia].[慢性淋巴细胞白血病]
Rinsho Ketsueki. 2014 Feb;55(2):213-22.
6
Combination therapy with fludarabine and rituximab followed by alemtuzumab in the first-line treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma: a phase 2 trial of the Minnie Pearl Cancer Research Network.氟达拉滨与利妥昔单抗联合治疗后使用阿仑单抗一线治疗慢性淋巴细胞白血病或小淋巴细胞淋巴瘤患者：米妮·珀尔癌症研究网络的2期试验
Cancer. 2008 Mar 15;112(6):1288-95. doi: 10.1002/cncr.23271.
7
Alemtuzumab by continuous intravenous infusion followed by subcutaneous injection plus rituximab in the treatment of patients with chronic lymphocytic leukemia recurrence.连续静脉输注阿仑单抗联合皮下注射利妥昔单抗治疗慢性淋巴细胞白血病复发。
Cancer. 2010 May 15;116(10):2360-5. doi: 10.1002/cncr.24958.
8
A phase II randomized trial comparing standard and low dose rituximab combined with alemtuzumab as initial treatment of progressive chronic lymphocytic leukemia in older patients: a trial of the ECOG-ACRIN cancer research group (E1908).一项II期随机试验，比较标准剂量和低剂量利妥昔单抗联合阿仑单抗作为老年进展性慢性淋巴细胞白血病初始治疗方案：东部肿瘤协作组-美国放射肿瘤学会癌症研究组（E1908）的一项试验
Am J Hematol. 2016 Mar;91(3):308-12. doi: 10.1002/ajh.24265. Epub 2016 Feb 9.
9
Impact of age on outcomes after initial therapy with chemotherapy and different chemoimmunotherapy regimens in patients with chronic lymphocytic leukemia: results of sequential cancer and leukemia group B studies.年龄对慢性淋巴细胞白血病患者初始化疗和不同化疗免疫治疗方案治疗后结局的影响：癌症和白血病组 B 研究的序贯结果。
J Clin Oncol. 2013 Feb 1;31(4):440-7. doi: 10.1200/JCO.2011.41.5646. Epub 2012 Dec 10.
10
Low dose alemtuzumab in patients with fludarabine-refractory chronic lymphocytic leukemia.氟达拉滨难治性慢性淋巴细胞白血病患者的低剂量阿仑单抗治疗。
Leuk Lymphoma. 2012 Mar;53(3):424-9. doi: 10.3109/10428194.2011.623258. Epub 2012 Jan 5.
引用本文的文献
1
Successful Treatment of Monoclonal Immunotactoid Glomerulopathy Associated with Chronic Lymphocytic Leukemia Using Ibrutinib.使用依鲁替尼成功治疗与慢性淋巴细胞白血病相关的单克隆免疫触须样肾小球病
Intern Med. 2025 May 1;64(9):1388-1392. doi: 10.2169/internalmedicine.3902-24. Epub 2024 Oct 4.
2
Long-term clinical course of immunotactoid glomerulopathy complicated with diffuse large B-cell lymphoma.免疫触须样肾小球病合并弥漫性大B细胞淋巴瘤的长期临床病程
CEN Case Rep. 2022 May;11(2):184-190. doi: 10.1007/s13730-021-00648-0. Epub 2021 Sep 26.
3
A case report of unusually long lag time between immunotactoid glomerulopathy (itg) diagnosis and diffuse large B-cell lymphoma (DLBCL) development.一例免疫触须样肾小球病（ITG）诊断与弥漫性大B细胞淋巴瘤（DLBCL）发生之间间隔时间异常长的病例报告。
BMC Nephrol. 2016 Sep 29;17(1):140. doi: 10.1186/s12882-016-0349-9.
本文引用的文献
1
Proliferative glomerulonephritis with monoclonal IgG deposits secondary to chronic lymphocytic leukemia. Report of two cases.继发于慢性淋巴细胞白血病的单克隆 IgG 沉积性增生性肾小球肾炎。两例报告。
Nephrol Dial Transplant. 2011 Aug;26(8):2712-4. doi: 10.1093/ndt/gfr251. Epub 2011 Jun 1.
2
Rare association of chronic lymphocytic leukemia/small lymphocytic lymphoma, ANCAs, and pauci-immune crescentic glomerulonephritis.慢性淋巴细胞白血病/小淋巴细胞淋巴瘤、ANCAs 和寡免疫性新月体性肾小球肾炎的罕见关联。
Am J Kidney Dis. 2011 Jan;57(1):170-4. doi: 10.1053/j.ajkd.2010.08.011. Epub 2010 Oct 25.
3
A phase I study of immune gene therapy for patients with CLL using a membrane-stable, humanized CD154.一项使用膜稳定型人源化 CD154 对 CLL 患者进行免疫基因治疗的 I 期研究。
Leukemia. 2010 Nov;24(11):1893-900. doi: 10.1038/leu.2010.191. Epub 2010 Sep 30.
4
Rituximab in combination with high-dose methylprednisolone for the treatment of chronic lymphocytic leukemia.利妥昔单抗联合大剂量甲泼尼龙治疗慢性淋巴细胞白血病
Leukemia. 2009 Oct;23(10):1779-89. doi: 10.1038/leu.2009.133. Epub 2009 Aug 20.
5
Chronic lymphocytic leukemia: a hazardous condition before kidney transplantation.
Am J Transplant. 2008 Nov;8(11):2471-5. doi: 10.1111/j.1600-6143.2008.02383.x. Epub 2008 Sep 8.
6
Rituximab in combination with high-dose methylprednisolone for the treatment of fludarabine refractory high-risk chronic lymphocytic leukemia.利妥昔单抗联合大剂量甲泼尼龙治疗氟达拉滨难治性高危慢性淋巴细胞白血病。
Leukemia. 2008 Nov;22(11):2048-53. doi: 10.1038/leu.2008.214. Epub 2008 Aug 28.
7
Concurrent FSGS and Hodgkin's lymphoma: case report and literature review on the link between nephrotic glomerulopathies and hematological malignancies.同时发生的局灶节段性肾小球硬化症和霍奇金淋巴瘤：关于肾病性肾小球病与血液系统恶性肿瘤之间联系的病例报告及文献综述
Clin Exp Nephrol. 2006 Dec;10(4):284-9. doi: 10.1007/s10157-006-0437-4. Epub 2006 Dec 20.
8
Minimal change glomerulonephritis in chronic lymphocytic leukemia: pathophysiological and therapeutic aspects.慢性淋巴细胞白血病中的微小病变性肾小球肾炎：病理生理及治疗方面
Onkologie. 2006 Apr;29(4):153-6. doi: 10.1159/000091644. Epub 2006 Mar 22.
9
Tumour lysis syndrome: new therapeutic strategies and classification.肿瘤溶解综合征：新的治疗策略与分类
Br J Haematol. 2004 Oct;127(1):3-11. doi: 10.1111/j.1365-2141.2004.05094.x.
10
Fibrillary glomerulonephritis and immunotactoid (microtubular) glomerulopathy are associated with distinct immunologic features.纤维性肾小球肾炎和免疫触须样（微管型）肾小球病具有不同的免疫学特征。
Kidney Int. 2002 Nov;62(5):1764-75. doi: 10.1046/j.1523-1755.2002.00628.x.
Zotero 插件